|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/14/20 Accolade, Inc. 10-Q 8/31/20 64:5.9M Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.08M
2: EX-10.8 Material Contract HTML 39K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
12: R1 Document and Entity Information HTML 75K
13: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 107K
14: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 40K
(Parenthetical)
15: R4 Condensed Consolidated Statements of Operations HTML 67K
(Unaudited)
16: R5 Condensed Consolidated Statements of Convertible HTML 110K
Preferred Stock and Stockholders' Deficit
(Unaudited)
17: R6 Condensed Consolidated Statements of Convertible HTML 21K
Preferred Stock and Stockholders' Deficit
(Unaudited) (Parenthetical)
18: R7 Condensed Consolidated Statements of Cash Flows HTML 103K
(Unaudited)
19: R8 Background HTML 24K
20: R9 Basis of Presentation and Summary of Significant HTML 58K
Accounting Policies
21: R10 Revenue HTML 38K
22: R11 Acquisition of MD Insider HTML 22K
23: R12 Fair Value Measurements HTML 55K
24: R13 Debt Facility HTML 37K
25: R14 Stockholders' Equity HTML 24K
26: R15 Equity-based Compensation and Warrants HTML 85K
27: R16 Income Taxes HTML 25K
28: R17 Net Loss Per Share Attributable to Common HTML 48K
Stockholders
29: R18 Commitments HTML 23K
30: R19 Change Healthcare Joint Development Agreement HTML 25K
31: R20 Basis of Presentation and Summary of Significant HTML 74K
Accounting Policies (Policies)
32: R21 Basis of Presentation and Summary of Significant HTML 52K
Accounting Policies (Tables)
33: R22 Revenue (Tables) HTML 27K
34: R23 Fair Value Measurements (Tables) HTML 53K
35: R24 Debt facility (Tables) HTML 27K
36: R25 Equity-based Compensation and Warrants (Tables) HTML 87K
37: R26 Net Loss Per Share Attributable to Common HTML 49K
Stockholders (Tables)
38: R27 Background - Initial Public Offering (Details) HTML 40K
39: R28 Basis of Presentation and Summary of Significant HTML 28K
Accounting Policies - Capitalized Internal-Use
Software Costs (Details)
40: R29 Basis of Presentation and Summary of Significant HTML 29K
Accounting Policies - Intangible Assets (Details)
41: R30 Basis of Presentation and Summary of Significant HTML 36K
Accounting Policies - Concentration of Credit Risk
(Details)
42: R31 Basis of Presentation and Summary of Significant HTML 26K
Accounting Policies - Deferred Offering Costs
(Details)
43: R32 Revenue - Revenue and Deferred Revenue (Details) HTML 34K
44: R33 Revenue - Revenue and Deferred Revenue Narratives HTML 24K
(Details)
45: R34 Revenue - Cost to obtain and fulfill a contract HTML 43K
(Details)
46: R35 Acquisition of MD Insider - Shares Issued HTML 32K
(Details)
47: R36 Fair Value Measurements (Details) HTML 27K
48: R37 Debt facility (Details) HTML 70K
49: R38 Debt facility - Warrant Rights (Details) HTML 54K
50: R39 Debt facility - Interest Payable (Details) HTML 33K
51: R40 Stockholders' Equity (Details) HTML 56K
52: R41 Equity-based Compensation and Warrants - Shares HTML 61K
(Details)
53: R42 Equity-based Compensation and Warrants - HTML 32K
Compensation expense (Details)
54: R43 Equity-based Compensation and Warrants - Award HTML 66K
Option (Details)
55: R44 Equity-based Compensation and Warrants - Equity HTML 36K
Instrument (Details)
56: R45 Income Taxes (Details) HTML 29K
57: R46 Net Loss Per Share Attributable to Common HTML 32K
Stockholders (Details)
58: R47 Net Loss Per Share Attributable to Common HTML 27K
Stockholders - Stock Options (Details)
59: R48 Commitments - Legal Proceedings (Details) HTML 22K
60: R49 Change Healthcare Joint Development Agreement HTML 42K
(Details)
62: XML IDEA XML File -- Filing Summary XML 113K
11: XML XBRL Instance -- tmb-20200831x10q_htm XML 1.13M
61: EXCEL IDEA Workbook of Financial Reports XLSX 69K
7: EX-101.CAL XBRL Calculations -- tmb-20200831_cal XML 105K
8: EX-101.DEF XBRL Definitions -- tmb-20200831_def XML 433K
9: EX-101.LAB XBRL Labels -- tmb-20200831_lab XML 1.04M
10: EX-101.PRE XBRL Presentations -- tmb-20200831_pre XML 721K
6: EX-101.SCH XBRL Schema -- tmb-20200831 XSD 132K
63: JSON XBRL Instance as JSON Data -- MetaLinks 282± 430K
64: ZIP XBRL Zipped Folder -- 0001558370-20-011470-xbrl Zip 250K
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Rajeev Singh, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Accolade, Inc. for the fiscal quarter ended August 31, 2020 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in such Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Accolade, Inc.
Date: October 14, 2020By:/s/
Rajeev Singh
Rajeev Singh
Chief Executive Officer
(Principal Executive Officer)
I, Stephen Barnes, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Accolade, Inc. for the fiscal quarter ended August 31, 2020 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in such Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Accolade, Inc.
Date: October 14, 2020By:/s/ Stephen Barnes
Stephen
Barnes
Chief Financial Officer
(Principal Financial Officer)
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/14/20 | 8-K | ||
| For Period end: | 8/31/20 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/26/24 Accolade, Inc. 10-K 2/29/24 98:9.3M 4/28/23 Accolade, Inc. 10-K 2/28/23 103:11M Toppan Merrill Bridge/FA 5/02/22 Accolade, Inc. 10-K 2/28/22 102:12M Toppan Merrill Bridge/FA 5/11/21 Accolade, Inc. POS AM 2:707K Toppan Merrill/FA 5/07/21 Accolade, Inc. 10-K 2/28/21 103:10M Toppan Merrill Bridge/FA 4/01/21 Accolade, Inc. S-1/A 4:3.7M Toppan Merrill/FA 3/15/21 Accolade, Inc. S-1 143:13M Toppan Merrill/FA 1/07/21 Accolade, Inc. 10-Q 11/30/20 63:6.3M Toppan Merrill Bridge/FA 10/19/20 Accolade, Inc. S-1 141:16M Toppan Merrill-FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/25/20 Accolade, Inc. 8-K:1,9 8/21/20 11:269K Toppan Merrill Bridge/FA 7/10/20 Accolade, Inc. 8-K:5,9 7/07/20 2:58K Toppan Merrill/FA 6/24/20 Accolade, Inc. S-1/A 5:5.7M Toppan Merrill-FA 6/16/20 Accolade, Inc. S-1/A 10:7.8M Toppan Merrill-FA 2/28/20 Accolade, Inc. S-1 39:24M Toppan Merrill-FA |